India, US to resume trade talks in Washington from April 20: Here’s what has changed

India and the US resumed trade negotiations in Washington from April 20, 2026, with a three-day round of talks focused on finalizing the first phase of the B...

What Happened

India and the US resumed trade negotiations in Washington from April 20, 2026, with a three-day round of talks focused on finalizing the first phase of the Bilateral Trade Agreement (BTA).
India's chief negotiator led a team of approximately a dozen officers, including officials from customs and the external affairs ministry.
The negotiating context has materially changed since the February 2026 framework agreement: a US Supreme Court ruling struck down sweeping tariffs that formed the foundation of the earlier framework, and the US subsequently imposed a uniform 10% tariff on all countries (for 150 days from February 24, 2026).
This uniform 10% tariff replaced a differentiated structure where India faced a 26% reciprocal tariff (imposed April 2, 2025, paused April 9–10, 2025 for 90 days).
The previously agreed framework — where the US reduced India's tariff from 25% to 18% in exchange for trade concessions — must now be recalibrated and redrafted given the changed tariff landscape.

Static Topic Bridges

India-US Bilateral Trade Agreement (BTA): Background and Structure

India and the US launched Bilateral Trade Agreement (BTA) negotiations in February 2025 at the level of heads of government. The trade relationship has historically been marked by significant asymmetries — India runs a goods trade surplus with the US (India's largest export destination), while the US has sought greater market access for American goods and agricultural products in India.

India's goods trade surplus with the US: India is a net exporter to the US; key Indian exports include pharmaceuticals, IT services, textiles, gems/diamonds, and engineering goods.
The February 2026 interim framework agreement included: US tariff reduction on Indian goods to 18% (from 25%); removal of the reciprocal tariff on pharmaceuticals, gems/diamonds, and aircraft parts; India pledging to eliminate or reduce tariffs on all US industrial goods and selected agricultural products (tree nuts, fresh/processed fruit, soybean oil, wine and spirits, DDGs, red sorghum).
India committed to purchasing $500 billion of US products over 5 years — including energy, aircraft, precious metals, technology products, and coking coal.

Connection to this news: The April 2026 Washington talks are the operational follow-through of the February framework — but the change in the US tariff baseline (from differentiated rates to a uniform 10%) requires the specific commercial terms to be renegotiated.

US Trade Policy Mechanism: IEEPA Tariffs and the Legal Challenge

The US tariffs on India were imposed using the International Emergency Economic Powers Act (IEEPA) — a US statute that grants the President broad authority to regulate economic transactions in a national emergency. The April 2025 tariff orders used IEEPA to impose "reciprocal" tariffs on trading partners.

Original tariff on India: 26% reciprocal tariff (Executive Order 14257, April 2, 2025).
90-day pause: April 9–10, 2025; baseline 10% duty maintained during the pause.
Subsequent development (2026): A US Supreme Court ruling curtailed the sweeping IEEPA-based tariff authority, triggering a restructuring. The Trump administration then imposed a uniform 10% tariff on all countries for 150 days (from February 24, 2026).
The uniform 10% structure eliminated the country-specific differentiation that had made a 18%-for-India deal commercially meaningful — the benefit of a preferential deal shrinks when the baseline tariff drops.

Connection to this news: The legal and policy shift in US tariff architecture is the direct reason talks had to be "recalibrated and redrafted" — what was a significant tariff benefit (18% vs. 26%) becomes less compelling when every country now pays only 10%.

World Trade Organization (WTO) Framework and Bilateral Agreements

India is a founding member of the WTO (established January 1, 1995, successor to GATT). Under WTO rules — specifically the Most-Favoured-Nation (MFN) principle (GATT Article I) — any trade advantage granted to one country must be extended to all WTO members, unless the arrangement qualifies as a Free Trade Agreement (FTA) under GATT Article XXIV, or a Generalised System of Preferences (GSP) under the Enabling Clause.

India's strategy in bilateral trade negotiations must balance WTO commitments (bound tariff rates) with the flexibility to offer preferential access in bilateral deals.
The US departure from MFN-consistent tariff rates via IEEPA is legally contested internationally; the WTO dispute settlement mechanism has been strained since the US blocked Appellate Body appointments.
India's bound tariffs under WTO are often significantly higher than applied tariffs — meaning India has room to lower applied tariffs bilaterally without violating WTO commitments on bound rates.
Key sensitive sectors for India in US trade negotiations include agriculture (dairy, oilseeds, GMO products) and financial services — where India maintains significant regulatory barriers that the US seeks to lower.

Connection to this news: The BTA must be structured as an FTA-like arrangement to be WTO-compatible; negotiators must ensure that tariff concessions do not violate either country's WTO obligations, while also navigating the changed US domestic legal landscape post-Supreme Court ruling.

India's Trade Policy Objectives

India's trade policy is guided by objectives of export promotion, import substitution in strategic sectors, and protecting domestic industry — particularly agriculture and MSMEs. The Ministry of Commerce and Industry administers trade policy; the Foreign Trade Policy (FTP) sets the broad framework.

India's merchandise trade deficit: India consistently imports more goods than it exports (goods trade deficit), partly offset by a services trade surplus (IT, BPO, tourism). The US is a major destination for both.
US demands in trade negotiations typically include: lower tariffs on agricultural products (dairy, poultry, oilseeds), greater market access for financial and digital services, and IPR (intellectual property rights) enforcement — particularly on pharmaceuticals.
India's pharmaceutical sector has been a contentious issue — India manufactures a large share of global generic medicines (including for the US market) and has resisted US demands for stronger patent protections that could limit generic competition.
India's key export sectors to the US: IT/BPO services (~$25 billion+), pharmaceuticals (~$7–8 billion), textiles/apparel, gems/jewellery, engineering goods.

Connection to this news: The April 2026 talks will test whether India can secure a tariff deal that protects pharmaceutical exports (currently at 0% under the framework) and IT services while meeting US expectations on agricultural market access and IPR — all within a restructured tariff environment.

Key Facts & Data

Trade talks location: Washington DC, from April 20, 2026 (three-day round)
India's chief negotiator: Darpan Jain (trade negotiator) with customs and MEA officials
February 2026 framework: US tariff on India reduced from 25% to 18%; 0% on pharma, gems, aircraft parts
Original US tariff on India: 26% reciprocal tariff (April 2, 2025, IEEPA-based)
Current US tariff baseline: 10% uniform on all countries (February 24 – July 2026)
India's $500 billion commitment: Purchase of US energy, aircraft, precious metals, technology, coking coal over 5 years
Indian export concessions: Tariff elimination/reduction on US industrial goods, select agri (tree nuts, soybean oil, fruit, wine, DDGs, sorghum)
WTO framework: MFN principle (GATT Article I); FTA exception (GATT Article XXIV)
WTO founding: January 1, 1995 (successor to GATT 1947)
India-US goods trade: India runs a surplus; US is India's largest single-country export destination
Key sensitive sectors: Agriculture, dairy, financial services, IPR/pharma for India in US negotiations